-
1
-
-
84855286477
-
Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus
-
Bennett W.L., Odelola O.A., Wilson L.M., et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus. Ann Intern Med 2012, 156:27-36.
-
(2012)
Ann Intern Med
, vol.156
, pp. 27-36
-
-
Bennett, W.L.1
Odelola, O.A.2
Wilson, L.M.3
-
2
-
-
37849039167
-
-
International Diabetes Federation, Brussels, Accessed February 21, 2013
-
International Diabetes Federation. IDF Diabetes Atlas 2012, International Diabetes Federation, Brussels, Accessed February 21, 2013. http://www.idf.org/diabetesatlas, 5th ed.
-
(2012)
International Diabetes Federation. IDF Diabetes Atlas
-
-
-
3
-
-
84876023480
-
Diabetes in Canada: Facts and Figures from a Public Health Perspective
-
Public Health Agency of Canada,Ottawa; 2011.
-
Public Health Agency of Canada. Diabetes in Canada: Facts and Figures from a Public Health Perspective. Ottawa; 2011.
-
-
-
-
4
-
-
34247637288
-
International Diabetes Federation: a consensus on type 2 diabetes prevention
-
Alberti K.G.M.M., Zimmet P., Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med 2007, 24:451-463.
-
(2007)
Diabet Med
, vol.24
, pp. 451-463
-
-
Alberti, K.G.M.M.1
Zimmet, P.2
Shaw, J.3
-
5
-
-
84872374890
-
Time for action: a Canadian proposal for primary prevention of type 2 diabetes
-
McManus R. Time for action: a Canadian proposal for primary prevention of type 2 diabetes. Can J Diabetes 2012, 36:44-49.
-
(2012)
Can J Diabetes
, vol.36
, pp. 44-49
-
-
McManus, R.1
-
6
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
-
(1993)
N Engl J Med
, vol.329
, pp. 977-986
-
-
-
7
-
-
29144453326
-
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
-
Nathan D.M., Cleary P.A., Backlund J.Y., et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353:2643-2653.
-
(2005)
N Engl J Med
, vol.353
, pp. 2643-2653
-
-
Nathan, D.M.1
Cleary, P.A.2
Backlund, J.Y.3
-
8
-
-
0037472879
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
-
Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
-
(2003)
N Engl J Med
, vol.348
, pp. 383-393
-
-
Gaede, P.1
Vedel, P.2
Larsen, N.3
-
9
-
-
38949210220
-
Effect of a multifactorial intervention on mortality in type 2 diabetes
-
Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
-
(2008)
N Engl J Med
, vol.358
, pp. 580-591
-
-
Gaede, P.1
Lund-Andersen, H.2
Parving, H.H.3
Pedersen, O.4
-
10
-
-
1542512011
-
Cost of illness studies in diabetes mellitus
-
Ettaro L., Songer T.J., Zhang P., Engelgau M.M. Cost of illness studies in diabetes mellitus. Pharmacoeconomics 2004, 22:149-164.
-
(2004)
Pharmacoeconomics
, vol.22
, pp. 149-164
-
-
Ettaro, L.1
Songer, T.J.2
Zhang, P.3
Engelgau, M.M.4
-
12
-
-
49649100471
-
Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes
-
Gaede P., Valentine W.J., Palmet A.J., et al. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes. Diabetes Care 2008, 31:1510-1515.
-
(2008)
Diabetes Care
, vol.31
, pp. 1510-1515
-
-
Gaede, P.1
Valentine, W.J.2
Palmet, A.J.3
-
13
-
-
33646684750
-
Consensus, cost-effectiveness and clinical practice guidelines: author's response
-
Harris S.B., McFarlane P., Lank C.N. Consensus, cost-effectiveness and clinical practice guidelines: author's response. Can J Diabetes 2005, 29:376-378.
-
(2005)
Can J Diabetes
, vol.29
, pp. 376-378
-
-
Harris, S.B.1
McFarlane, P.2
Lank, C.N.3
-
14
-
-
34548385738
-
Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation
-
Consensus Committee
-
Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400. Consensus Committee.
-
(2007)
Diabetes Care
, vol.30
, pp. 2399-2400
-
-
-
15
-
-
84869790085
-
Measurement of hemoglobin A1c: a new twist on the path to harmony
-
Sacks D. Measurement of hemoglobin A1c: a new twist on the path to harmony. Diabetes Care 2012, 35:2674-2680.
-
(2012)
Diabetes Care
, vol.35
, pp. 2674-2680
-
-
Sacks, D.1
-
16
-
-
39749107290
-
The IFCC reference measurement system for HbA1c: a 6-year progress report
-
Weykamp C., John W.G., Mosca A., et al. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 2008, 54:240-248.
-
(2008)
Clin Chem
, vol.54
, pp. 240-248
-
-
Weykamp, C.1
John, W.G.2
Mosca, A.3
-
17
-
-
84876014866
-
Type 2 diabetes mellitus management in Canada: Is it improving?
-
in press.
-
Leiter LA, Berard L, Bowering K, et al. Type 2 diabetes mellitus management in Canada: Is it improving? Can J Diabetes 2013: in press.
-
(2013)
Can J Diabetes
-
-
Leiter, L.A.1
Berard, L.2
Bowering, K.3
-
18
-
-
38349012958
-
Adding "value" to clinical practice guidelines
-
McCormack J.P., Loewen P. Adding "value" to clinical practice guidelines. Can Fam Physician 2007, 53:1326-1327.
-
(2007)
Can Fam Physician
, vol.53
, pp. 1326-1327
-
-
McCormack, J.P.1
Loewen, P.2
|